The Patent Finder

Terms ending in 2035

Bayer Pharma Aktiengesellschaft

Every in-force patent on Bayer Pharma Aktiengesellschaft's record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 9,951,027BENZIMIDAZOL-2-Amines as MIDH1 Inhibitors
In force
 · High confidence
Deutsches Krebsforschungszentrum, Stiftung des Öffentlichen RechtsIn forceHigh confidence
US 10,155,950Immunostimulatory Plasmids
In force
 · High confidence
Elanco Animal Health GmbHIn forceHigh confidence
US 10,851,379Immunostimulatory Plasmids
In force
 · High confidence
Elanco Animal Health GmbHIn forceHigh confidence
US 9,771,360Cyano-Substituted Imidazo[1,2-a]pyridinecarboxamides and Their Use
In force
 · High confidence
Bayer Pharma AktiengesellschaftIn forceHigh confidence
US 10,046,110Lock for Drug Injection Device
In force
 · High confidence
Bayer Pharma AktiengesellschaftIn forceHigh confidence
US RE49,575Method for the Preparation of (4S)-4-(4-Cyano-2-Methoxyphenyl)-5-Ethoxy-2,8-Dimethyl-1,4-Dihydro-1-6-Naphthyridine-3-Carbox-AMIDE and the Purification Thereof for Use as an Active Pharmaceutical Ingredient
In force
 · Low confidence
Bayer Pharma AktiengesellschaftIn forceLow confidence
US RE49,826Method for the Preparation of (4S)-4-(4-Cyano-2-Methoxyphenyl)-5-Ethoxy-2,8-Dimethyl-1,4-Dihydro-1-6-Naphthyridine-3-Carboxamide and the Purification Thereof for Use as an Active Pharmaceutical Ingredient
In force
 · Low confidence
Bayer Pharma AktiengesellschaftIn forceLow confidence
US RE49,860Process for Preparing (4S)- 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide and Purification Thereof for Use as a Pharmaceutical Active Ingredient
In force
 · Low confidence
Bayer Pharma AktiengesellschaftIn forceLow confidence
US 9,549,9322-(MORPHOLIN-4-YL)-1,7-Naphthyridines
In force
 · High confidence
Bayer Pharma AktiengesellschaftIn forceHigh confidence
US 10,729,6805-Substituted 2-(MORPHOLIN-4-YL)-1,7-Naphthyridines
In force
 · High confidence
Bayer Pharma AktiengesellschaftIn forceHigh confidence
17 more term ends in 2035 · Pro
10 of 27 patents shown. Soonest term end first, then patent number.
Pro members see all 27.
Upgrade to Pro
18 of these are in force and held by Bayer Pharma Aktiengesellschaft.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited